Approval · Notice of Compliance 32586 · 2024
PMS-LOPERAMIDE: Notice of Compliance 32586
Issued January 23, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32586
- Date
- January 23, 2024
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to Product Monograph to be in line with CRP
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PMS-LOPERAMIDE | 02228351 | Marketed |
| PMS-LOPERAMIDE HYDROCHLORIDE SOLUTION | 02016095 | Marketed |
Medicinal ingredients
- LOPERAMIDE HCL 2 MG per TAB
- LOPERAMIDE HCL 0.2 MG per ML